Correction to Philippines Suspends Dengue Drug Article

Features Dow Jones Newswires

Sanofi asked regulators to change the vaccine label to recommend that people don't take the vaccine if they haven't been previously been infected. "Philippines Suspends Troubled Dengue Drug After More Than 730,000 Immunized," at 0832 GMT, incorrectly stated the recommendation was that people shouldn't take the vaccine if they have been previously infected in the fourth paragraph. (Dec. 4)

Continue Reading Below

(END) Dow Jones Newswires

December 04, 2017 06:48 ET (11:48 GMT)